Company to host call at 11:00 a.m. ET
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 26, 2015--
POZEN Inc. (NASDAQ: POZN) today announced that the Company plans
to release results for the third quarter 2015 on Monday, November 9,
2015, before the opening of the U.S. markets. The Company also will
conduct a conference call that day at 11:00 a.m. ET to discuss results
and highlights of the third quarter of 2015. The presentation slides to
be used during the call will be available on the "Investors" section of
the Company's website under the "Overview" tab beginning at 11:00 a.m.
ET on Monday, November 9, 2015.
A live webcast of the conference call, presentation and question and
answer session will be available on the "Investors" section of the
Company's website under the "Overview" tab. To access the live webcast,
please log on to POZEN's site approximately 15 minutes prior to the
presentation to register and download any necessary audio software. The
presentation replay will be available for 90 days after the event.
Conference call details:
Date: Monday, November 9, 2015
11:00 a.m. ET
Dial-in (U.S.): 877-407-8037
POZEN Inc. is a specialty pharmaceutical company that to date has
historically focused on developing novel therapeutics for unmet medical
needs and licensing those products to other pharmaceutical companies for
commercialization. By utilizing a unique in-source model and focusing on
integrated therapies, POZEN has successfully developed and obtained FDA
approval of two self-invented products. Funded by these
milestones/royalty streams, POZEN has created a portfolio of
cost-effective, evidence-based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI damage.
POZEN’s common stock is traded under the symbol “POZN” on The NASDAQ
Global Market. For more detailed company information, including copies
of this and other press releases, please visit www.pozen.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151026005159/en/
Source: POZEN Inc.
Bill Hodges, Chief Financial Officer
Ochsner, Executive Director,
Investor Relations & Corporate